chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a 90 year old male patient reporting on himself, with allergy to Sulfazine, diabetes mellitus and hypertension, colitis ulcerative and prostate cancer. Approximately, in 2008 (reported as "8 years ago") the patient was vaccinated with ZOSTAVAX 1 shot, subcutaneous. Dose, lot number and expiration date were not provided. Concomitant therapies included ALTACE, finasteride(manufacturer unknown), ACTOS, tamsulosin hydrochloride(manufacturer unknown, OXBYBUTYNIN and simvastatin(manufacturer unknown). Approximately, on 20-APR-2016 ("reported as two and a half months ago") the patient experienced an outbreak of Shingles. The patient had blisters developed around the eyelid and on the right side of his face, as well as the area around the eye socket an don his right temple. On an unknown date, in 2016, the  blistered area was also swollen, which had an effect on his eyelid opening and closing (eyelid function disorder). Also, the patient stated that on the first 48 hours of the Shingles experienced a extreme headaches, which prevented him from sleeping (sleeping disorder). The outcome of Shingles, eyelid function disorder, sleep disorder and headache was reported as recovering. The causality between the events and the therapy with ZOSTAVAX was unknown. Additional information has been requested.
2nd shot 2 years after the 1st; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (on an unknown date received 1st dose in July 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.      Additional Information: GSK Receipt Date: 01-DEC-2022 Reporter's Comment: The inquiry came in via chat and pharmacist reported only partial data. The reporter wanted to know was it considered a completed series if the second Shingrix shot was 2 years after the 1st shot. The Hcp (health care professional) provided date July 2019 but it was unclear if its 1st or 2nd dose. The chat ended by user no consent was obtained for follow up. Additional Supportive Information: The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of the vaccine schedule.
I was already experiencing symptoms from a mold exposure. I was having chest pains when breathing and sharp pains near my lungs. I also started to experience fatigue, brain fog and back pain. After the vaccine the symptoms have gotten worse. I did have a visit with my doctor about my symptoms worsening and I was given a referral for physical therapy. I now have to go to physical therapy for the back pain. My doctor states if the physical therapy does not work then we will do more testing.
22 year old female received 1st dose of Pfizer COVID 19 vaccine on 13 Sept 2021 at approx. 1545. Patient stated she's incredibly nervous with shots.  Immediately following the shot the patient stated she was lightheaded. Approx. 20 seconds after the show the patient had a syncope episode. Patient stated feeling nauseous approx. 30 seconds following the shot. The vaccine team called for assistance at this time. Vital signs were taken. Approx. 5 minutes after the episode the patient stated she feels completely better. Patient/Father of patient was informed that they would be taken to the Emergency Room based on the hospital protocol.
Ringing in ears. Started about an hour after I got my shots. Slightly increased/worse today.  I can still hear fine but it?s significant tinnitus.  I?ve not reported to my doctor yet. Will if it doesn?t go away within 10 days.
On 12/7/12 patient received 2 vaccinations in left deltoid region - PNEUMOVAX, FLUVIRIN. On 12/10/12, patient was reported to have edema and swelling at injection site. Patient was treated by MD and prescribed KEFLEX. Reaction was not differentiated between adverse effect or cellulitis. Patient recovered and well.
Red achy  at injection site at first for about 3 days then went away. About  10 days later the red area came back and patient is feeling nauseated and having diarrhea.
my two middle fingers on my right hand went permanently numb; had chiropractic appointments, hand specialist and finally Carpal Tunnel release surgery and my fingers are still numb; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (Unknown). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 25Jul2022 as dose number unknown (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, manufacturer: Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose: 1st booster), for COVID-19 immunization. The following information was reported: CARPAL TUNNEL SYNDROME (medically significant) with onset 2022, outcome "unknown", described as "had chiropractic appointments, hand specialist and finally Carpal Tunnel release surgery and my fingers are still numb"; HYPOAESTHESIA (non-serious) with onset Jul2022, outcome "not recovered", described as "my two middle fingers on my right hand went permanently numb". The events "had chiropractic appointments, hand specialist and finally carpal tunnel release surgery and my fingers are still numb" and "my two middle fingers on my right hand went permanently numb" required physician office visit. Additional information: On 25Jul2022 patient second booster in right arm. The end of Jul2022 her two middle fingers on her right hand went permanently numb. Since then, She had chiropractic appointments, hand specialist and finally Carpal Tunnel release surgery and her fingers are still numb.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
For the past three years I have noticed a pattern in my children; A display of sudden FLU symptoms such as: fever, body ache, weakness, chills when their classmates get the FLU MIST vaccine at school.
Patient had a high fever of 102 degrees F, severe body pains for 2 weeks, nerve pain and tingling sensation for weeks. Pt didn't feel well at all and is unwilling to get the vaccine second dose.
Pt. states an hour after, she started a 2-3/10 headache, after 2hrs, she had 7-8/10 headache. Tylenol 1000mg PO taken. After 5 hours, she was very fatigued, headache 5/10. Fell asleep. Fever started during the night, when she woke up today 12/23/20 @ 6AM, it was 101.3 - she had a cold shower and had a headache of 5/10. She took tylenol 1000mg PO at 6:30AM. at 8:30AM, temp. is 99 degrees and headache gone.
Mother called into clinic on 6/3 due to patient "crying" most of the night and when he woke on 6/3 his left thigh was hard, swollen and red. Patient did not have a fever. As the day progressed redness on patient's thigh spread and it was hot to the touch. Mother reports that patient cried if anyone touched his thigh. Patient was taken to Emergency Department and was diagnosed with cellulitis and prescribed antibiotics. RN saw patient on 6/6 and redness had improved. Photos were taken and uploaded into the chart. It appears that vaccine was given in middle of thigh and not laterally.
Wrong Medicine Administered; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong Medicine Administered) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong Medicine Administered). At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong Medicine Administered) outcome was unknown.            There was no treatment medication reported by the reporter.
"A couple" / received / first dose / 30AUG2018 / have not / received the next; This case was reported by a pharmacist via other manufacturer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on 30th August 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follow: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. The reporter declined to provide further adverse events details or information.  No additional adverse events reported.  No additional information reported. This case had been linked with US2021AMR170406, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR170406:Same reporter. Patient 1/2.
aortic aneurysms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 57-year-old female patient received BNT162b2 (BNT162B2), on 03Dec2021 as dose 3 (booster), single (Lot number: FJ8762) at the age of 56 years intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history included: "Thyroid" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE taken for thyroid disorder (ongoing). Vaccination history included: BNT162b2 (1st dose: Date: 06Apr2021 NDC number, lot number, expiration date: Lot number ER8734.), administration date: 06Apr2021, when the patient was 56-year-old, for Covid-19 immunization, reaction(s): "aortic aneurysms"; BNT162b2 (2nd dose: Date: 27Apr2021 NDC number, lot number, expiration date: EW0172), administration date: 27Apr2021, when the patient was 56-year-old, for Covid-19 immunization, reaction(s): "aortic aneurysms". The following information was reported: AORTIC ANEURYSM (medically significant) with onset 18Oct2022, outcome "unknown", described as "aortic aneurysms". Therapeutic measures were taken as a result of aortic aneurysm.  Clinical course: It was reported by the patient that she had aortic aneurysms after getting the 3 Pfizer covid-19 vaccine. She was looking for more information if we know anything about this and if there was a correlation between them. Caller noted that if google searched the reports of aortic aneurysms are available, and that they're also doing a clinical trial about this. Start date of adverse event was initially stated maybe 18Oct2022, then caller clarified caller was not sure, not a medical professional, does not know what day aortic aneurysm started. The reporter also stated that going to have to have open heart surgery, confirmed has not had open heart surgery yet. The event requires the initiation of new medication/other treatment/ procedure was provided as yes. Vaccination facility type was pharmacy. Vaccine was not administered at Military Facility. No prior Vaccinations within 4 weeks.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201380747 Same reporter, same patient/AE and  different dose;US-PFIZER INC-202201380791 Same reporter, same patient/AE and  different dose;
Information has been received via social media (website) regarding a 5-week old female, who on an unspecified date received the RECOMBIVAX HB. The parent (not further specified if a mother or father) reported that "My 5-week old daughter died within hours of getting the Hepatitis B vaccine." No further information was reported.
Administered to a child under 10 years old; Administered to a child under 10 years old; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 19-month-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 57DE9, expiry date 12th November 2023) for prophylaxis.   On 30th August 2022, the patient received Boostrix. On 30th August 2022, unknown after receiving Boostrix, the patient experienced underdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the underdose and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 30-Aug-2022 Reporter's comments: Nurse practitioner reported that Boostrix was administered to a child under 10 years of age on 30th August 2022. The reporter had consented to follow-up with the safety team. Additional supportive information: The patient who had received Boostrix was younger than 10 years which had led to underdose and inappropriate age at vaccine administration.
Flu symptoms, cold. fever, all over achiness and lack of energy.  I ended up in bed for 5 - 6 days, and I have not been this sick since I had the flu in the 80's.  I also had a large (3-4 inch bruise at the site of the injection.  I get the flu shot every year and have never had this kind of reaction.  I had not been in contact with anyone who was sick before I received the flu shot.
Itching head to toe and pulse was high. next day I felt vert fatigued and headache.
7JUL to 1AUG pt exp high fever ranging from 104-101 was hospitalized-rash head to toe, sore throat, cough, congestion, wheezing in chest was released on ATB;
TWITCHING AT THE INJECTION SITE; This spontaneous report received from a pharmacist concerned a 31 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and alcoholic, and other pre-existing medical conditions included the patient had no known allergies. The patient did not have any history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1821281 expiry: 23-JUL-2021) dose was not reported, administered on 07-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-JUN-2021, the subject experienced twitching at the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from twitching at the injection site on 07-JUN-2021. This report was non-serious.
I have family members who are injured or dead due to your company's potential unethical experiments and negligence; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP), Program.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as DOSE NUMBER UNKNOWN, SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal" described as "I have family members who are injured or dead due to your company's potential unethical experiments and negligence." The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  Additional information: The reporter asked, "Why is Pfizer doing gain of function research to mutate Covid viruses as (Withheld) talked to the Project reporter last week? I have family members who are injured or dead due to your company's potential unethical experiments and negligence."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: I have family members who are injured or dead due to your companies potential unethical experiments and negligence.
A consumer report has been received. The report concerns a 3 year old, Female consumer, who had been receiving FLUMIST (intranasal). FLUMIST (intranasal) started on an unknown date. The patient experienced stuffy nose and runny nose. The outcome of the event of stuffy nose and runny nose is unknown. The report was considered to be non-serious.
This spontaneous report as received from a registered nurse refers to unspecified patients. The patient's medical history was not reported. On an unknown date the unspecified patients were vaccinated with doses of GARDASIL (Lot #, dose and route were not reported) that were exposed to a supported temperature excursion on unspecified dates. No adverse experience has been observed or reported. No product quality complaint (PQC) was reported for GARDASIL. Follow up information has been received from a registered nurse. The reporter stated that on 13-AUG-2014 one of the three patients were administered with GARDASIL (lot number and expiration date not reported). Follow up information has been received from a license practical nurse. The reporter specified the 13 year old patient was vaccinated on 13-AUG-2014 with GARDASIL (Lot # J006850, exp. date 31-MAR-2016). Also, it was reported not all doses with this lot # were affected by the temperature excursion, it was not known which clients received the affected doses. None of the clients have reported an adverse event from receiving the vaccine. This is one of several cases from the same source. Additional information has been requested.
Noticed a 15cm x 9 cm erythema area on Left upperarm. Two hard lumps contained within the erythemous area. Positive for pruritis.
PFIZER COVID-19 BIONTECH EUA: Patient described getting hives on the left side of her body. The same side as the COVID vaccine was given. She said she did not have any trouble breathing, but the hives did itch.  They showed up 3 days after her vaccine and lasted about 1 week but did resolve.
Developed large aggressive amounts of granulation in lungs; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY GRANULOMA (Developed large aggressive amounts of granulation in lungs) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 037BEIA) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS and Heart disease, unspecified.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PULMONARY GRANULOMA (Developed large aggressive amounts of granulation in lungs) (seriousness criterion medically significant). At the time of the report, PULMONARY GRANULOMA (Developed large aggressive amounts of granulation in lungs) outcome was unknown.            Patient's laboratory details reported included CAT scan (computed axial tomography) for which result was not specified. At the time of report patient was under doctor's care and doing better.  No concomitant medication information was reported.  No treatment information was reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
The first reaction began 5 days after the covid vacccine. Initial symptoms were painful, shooting, burning pains that radiated from the inject site down his arm and into back. Patient was unable to perform his daily activities. He is a captain at the fire dept., and also unable to pick up his daughter due to pain and burning. He was seen by a PCP due to the pain, and an EKG and blood work was performed to rule out another cause, and all was normal. He was then prescribed gabapentin and prednisone, and given toradol 60mg IM and Decadron 10mg IM in office. The pain diminished slightly and after 3 days the pain was severe again, and he was sent to neurology on September 2.
Patient experienced near syncopal episode following his vaccine: Within 3-4 minutes following administration of Pfizer Covid-19 vaccine patient reported feeling lightheaded and dizzy.  Patient was found to be pale and slightly diaphoretic.  Patient was helped to supine position with legs elevated and rested while symptoms fully subsided. Pt was able to answer questions about himself and his symptoms throughout duration of event and did not lose consciousness.   Patient was monitored closely for an additional 45 minutes, VS monitored and  provided with a light snack and water.  After full resolution of symptoms patient was escorted to his car with parent. Mom was provided with education regarding the event and signs and symptoms to monitor.
Localized area swelling, induration 15 cm long by 14 cm wide oval shaped left lateral thigh.
pt recv vax & devel fever PM & tonic-clonic sz @ around 715PM lasting 8min prior to arrival;in ER noted to be in status epilepticus;
Intermittent visual aura in peripheral of right eye; can be described as a flickering or flash. History of migraine with aura, however, this aura behaves differently  (i.e. this aura only appears on the "outskirt" of field of vision, only in one eye, lasts for a split second, and occurs several times throughout the day).
01/01/2022:  Event occurred after 2nd vaccine. 82-year-old female past medical history hypertension, hyperlipidemia, anxiety left bundle branch block and remote history of throat cancer presenting for chest pain or shortness of breath.  Patient states for the past 3 days or so she has had shortness of breath. She states that she has felt feverish and unwell and she has had a nonproductive.  cough.+fever, +generalized weakness.
12/26/21 presents to Triage for "G2P1001" "ctxs". PMHx of "Bipolar disorder" "Chicken pox"  "
I had itching around my waist that looked like shingles (rash and bumps).  I called doctor to get a test done. Returned negative. Acyclovir was prescribed for 7 day course. Seems to have worked. Also had issue with fatigue, lack of appetite, pain in gallbladder area. Was sent to ER by order of PCP. After 3 tests were done it was determined I had a gall stone. Was advised to get referral to surgeon for consult. Currently waiting for PCP to give referral for evaluation. NOTE: Flu Vaccine was given on 11/5/2021 before issue with gall stone.
She had pneumovax and prevnar not working; This is a spontaneous report from two contactable physicians from a Pfizer-sponsored program. A 69-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunisation, pneumococcal vaccine polysacch 23v (PNEUMOVAX), via an unspecified route of administration on an unspecified date at unknown dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced she had pneumovax and prevnar not working  on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: The association between the event "prevenar not working" with pneumococcal 13-valent conjugate vaccine can not be fully excluded.
Severe aches in both legs as well as body aches, fatigue, fever of 100.0.